| Cynthia C Lodding, MD | |
|
164 High Street, Greenfield, MA 01301 | |
| (413) 773-2263 | |
| Not Available |
| Full Name | Cynthia C Lodding |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 18 Years |
| Location | 164 High Street, Greenfield, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346456688 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 245955 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
Decreased affect recognition is associated with psychosis vulnerability, but it is not a marker of conversion to psychosis in high-risk individuals, researchers report.
Cerenis Therapeutics SA (Cerenis), a biopharmaceutical company specializing in the research and development of novel therapies based on the metabolism of HDL (the "good" cholesterol) to treat cardiovascular and other metabolic diseases, announced today it has raised €40 million in the first close of its series C financing. In this round €20 million came from the Fund for Strategic Investment (FSI) with an additional €20 million coming from the existing investors: Sofinnova Partners, HealthCap, Alta Partners and TVM Capital, EDF Ventures, OrbiMed and DAIWA Corporate Investment.
Children with profound deafness who receive a cochlear implant had as much as five times the risk of having delays in areas of working memory, controlled attention, planning and conceptual learning as children with normal hearing, according to Indiana University research published May 22 in the Journal of the American Medical Association Otolaryngology-Head and Neck Surgery.
Research toward the world's first vaccine for heart disease continues to advance at the La Jolla Institute for Allergy and Immunology, with researchers demonstrating significant arterial plaque reduction in concept testing in mice.
› Verified 8 days ago
| Entity Name | Emergency Physicians Integrated Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578598199 PECOS PAC ID: 4284548116 Enrollment ID: O20031115000013 |
News Archive
Decreased affect recognition is associated with psychosis vulnerability, but it is not a marker of conversion to psychosis in high-risk individuals, researchers report.
Cerenis Therapeutics SA (Cerenis), a biopharmaceutical company specializing in the research and development of novel therapies based on the metabolism of HDL (the "good" cholesterol) to treat cardiovascular and other metabolic diseases, announced today it has raised €40 million in the first close of its series C financing. In this round €20 million came from the Fund for Strategic Investment (FSI) with an additional €20 million coming from the existing investors: Sofinnova Partners, HealthCap, Alta Partners and TVM Capital, EDF Ventures, OrbiMed and DAIWA Corporate Investment.
Children with profound deafness who receive a cochlear implant had as much as five times the risk of having delays in areas of working memory, controlled attention, planning and conceptual learning as children with normal hearing, according to Indiana University research published May 22 in the Journal of the American Medical Association Otolaryngology-Head and Neck Surgery.
Research toward the world's first vaccine for heart disease continues to advance at the La Jolla Institute for Allergy and Immunology, with researchers demonstrating significant arterial plaque reduction in concept testing in mice.
› Verified 8 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
Decreased affect recognition is associated with psychosis vulnerability, but it is not a marker of conversion to psychosis in high-risk individuals, researchers report.
Cerenis Therapeutics SA (Cerenis), a biopharmaceutical company specializing in the research and development of novel therapies based on the metabolism of HDL (the "good" cholesterol) to treat cardiovascular and other metabolic diseases, announced today it has raised €40 million in the first close of its series C financing. In this round €20 million came from the Fund for Strategic Investment (FSI) with an additional €20 million coming from the existing investors: Sofinnova Partners, HealthCap, Alta Partners and TVM Capital, EDF Ventures, OrbiMed and DAIWA Corporate Investment.
Children with profound deafness who receive a cochlear implant had as much as five times the risk of having delays in areas of working memory, controlled attention, planning and conceptual learning as children with normal hearing, according to Indiana University research published May 22 in the Journal of the American Medical Association Otolaryngology-Head and Neck Surgery.
Research toward the world's first vaccine for heart disease continues to advance at the La Jolla Institute for Allergy and Immunology, with researchers demonstrating significant arterial plaque reduction in concept testing in mice.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cynthia C Lodding, MD 164 High Street, Greenfield, MA 01301 Ph: (413) 772-0211 | Cynthia C Lodding, MD 164 High Street, Greenfield, MA 01301 Ph: (413) 773-2263 |
News Archive
Decreased affect recognition is associated with psychosis vulnerability, but it is not a marker of conversion to psychosis in high-risk individuals, researchers report.
Cerenis Therapeutics SA (Cerenis), a biopharmaceutical company specializing in the research and development of novel therapies based on the metabolism of HDL (the "good" cholesterol) to treat cardiovascular and other metabolic diseases, announced today it has raised €40 million in the first close of its series C financing. In this round €20 million came from the Fund for Strategic Investment (FSI) with an additional €20 million coming from the existing investors: Sofinnova Partners, HealthCap, Alta Partners and TVM Capital, EDF Ventures, OrbiMed and DAIWA Corporate Investment.
Children with profound deafness who receive a cochlear implant had as much as five times the risk of having delays in areas of working memory, controlled attention, planning and conceptual learning as children with normal hearing, according to Indiana University research published May 22 in the Journal of the American Medical Association Otolaryngology-Head and Neck Surgery.
Research toward the world's first vaccine for heart disease continues to advance at the La Jolla Institute for Allergy and Immunology, with researchers demonstrating significant arterial plaque reduction in concept testing in mice.
› Verified 8 days ago
Thomas Hagamen, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 164 High St, Greenfield, Greenfield, MA 01301 Phone: 413-773-2263 | |
Jennifer M Dohrmann, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 164 High St, Greenfield, MA 01301 Phone: 413-772-2263 Fax: 413-773-2127 | |
Dr. Lucas Charles Rosiere, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 164 High St, Greenfield, MA 01301 Phone: 413-773-0211 | |
Mr. Kenneth Grantland Christian Iii, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 164 High St, Greenfield, MA 01301 Phone: 413-773-2263 | |
Laura Taylor Director, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 164 High St, Greenfield, MA 01301 Phone: 413-773-2263 Fax: 413-773-2127 | |
Dr. Michael David Dunkerley, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 164 High St, Franklin Medical Center- Dept Of Emergency Medicine, Greenfield, MA 01301 Phone: 413-773-2581 | |
Nathan T Wilson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 164 High Street, Greenfield, MA 01301 Phone: 413-773-2263 |